The Front Room — a clinical regulatory commons
RSS
← Back to The Docket
SEP 11 2026
UPCOMING · 42 DAYS TO PDUFA

Telix Pharmaceuticals Limited Pixclara (TLX101-Px) $TLX

for brain cancer imaging

NDA · Fast Track · Orphan

Accepted APR 10 2026.

About

Pixclara is a radioactive imaging agent designed to target and illuminate brain cancer tissue. It delivers a radioactive tracer that binds to a specific target found on the surface of cancer cells. This allows doctors to visualize the location and extent of the disease, which could help guide more precise treatment decisions.